We report here for the first time that Peptide 19-2.5 attenuates the IRS-1 phosphorylation in the liver, diabetic nephropathy (proteinuria), hypercholesterolemia and steatohepatitis caused by HFD in the mouse. Here, IRS1 is linked to Hypercholesterolemia.